A new method for early detection of pancreatic cancer biomarkers: detection of microRNAs by nanochannels
Source abstract
Abstract
Objective: To develop an effective new method for early detection of pancreatic cancer biomarkers and to aid early clinical diagnosis. Methods: A DNA probe (Probe) capable of specifically recognizing the target miRNA was designed. The specific probe of miRNA 21 is designed first, and then mixed with the miRNA 21 sample to form a complex molecule, and the complex molecule is added to the nanochannels to detect the received signal. The probe is designed to detect the electrical signal by means of pre-matching and post-matching and observe the stability of the signal. The miRNA 21, miRNA 155, miRNA 196a were added to the nano-single channel to detect the characteristic signals and blocking time. The miRNA 21·probe 21 mixture was mixed with other five cancer-associated microRNAs, and the signal results of the detection were collected and compared. Results: The signal of miRNA 21 was successfully detected. Whether the probe is designed at the front or the back, there are two signal results. The Probe should be designed to match the middle region of the miRNA. The three microRNA complex molecules have different characteristic signals and blocking times, which can be effectively distinguished. Conclusion: Nanochannels can effectively detect pancreatic cancer-related microRNAs.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanopore and Nanochannel Transport Studies · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pathology, the First Affiliated Hospital of Nanchang University
Department of Clinical Laboratory, the Second Affiliated Hospital of Nanchang University
Department of Burns, the First Affiliated Hospital of Nanchang University
References (35)
Show source-provided references
1. 10.1002/elps.20140007510.1002/elps.201400075 ↗
2. 10.1038/nprot.2007.52810.1038/nprot.2007.528 ↗
3. 10.1073/pnas.93.24.1377010.1073/pnas.93.24.13770 ↗
4. 10.6023/A1607035210.6023/A16070352 ↗
5. 10.1016/j.copbio.2017.11.00610.1016/j.copbio.2017.11.006 ↗
6. 10.1038/nbt.217110.1038/nbt.2171 ↗
7. 10.1038/nmeth.229210.1038/nmeth.2292 ↗
8. 10.1021/bi060483510.1021/bi0604835 ↗
9. 10.1021/nl049413e10.1021/nl049413e ↗
10. 10.1021/ac102987410.1021/ac1029874 ↗
11. 10.6023/A1709043310.6023/A17090433 ↗
12. 10.1021/acsnano.6b0573710.1021/acsnano.6b05737 ↗
13. 10.1016/j.omtn.2017.11.00810.1016/j.omtn.2017.11.008 ↗
14. 10.1002/wrna.145210.1002/wrna.1452 ↗
15. 10.1021/jp309541h10.1021/jp309541h ↗
16. 10.1021/am500749p10.1021/am500749p ↗
17. 10.1093/clinchem/18.6.51910.1093/clinchem/18.6.519 ↗
18. 10.1016/j.canlet.2017.09.04310.1016/j.canlet.2017.09.043 ↗
19. 10.1016/j.nano.2016.11.01510.1016/j.nano.2016.11.015 ↗
20. 10.1038/nature0370210.1038/nature03702 ↗
21. 10.1158/0008-5472.CAN-05-178310.1158/0008-5472.CAN-05-1783 ↗
22. 10.1038/cr.2008.28210.1038/cr.2008.282 ↗
23. Yuan Y, Ru Q. Progress of microRNA detection technology and its application in laboratory medicine. Med Information. 2011;8:3809–3809.
24. Shi M, Qiu X, Fan H. Advances in plasma miRNA detection in tumor clinical applications. J Southeast Univ (Med Sci Edi). 2012;21:122–125.
25. 10.1016/j.cell.2008.12.02710.1016/j.cell.2008.12.027 ↗
26. 10.1371/journal.pone.001373510.1371/journal.pone.0013735 ↗
27. Xueying Z, Linlin Z, Xuedong HAN, et al. Circulating miR-21 in plasm of patient with breast cancer. Modern Med J. 2012;40:133–137.
28. 10.1021/acs.analchem.7b0124610.1021/acs.analchem.7b01246 ↗
29. 10.1021/nn506031710.1021/nn5060317 ↗
30. 10.1038/9023610.1038/90236 ↗
31. 10.1016/j.bpj.2015.11.02010.1016/j.bpj.2015.11.020 ↗
32. 10.1016/j.bpj.2009.12.433310.1016/j.bpj.2009.12.4333 ↗
33. 10.1021/acs.analchem.7b0473710.1021/acs.analchem.7b04737 ↗
34. 10.1038/s41467-018-06873-z10.1038/s41467-018-06873-z ↗
35. 10.1002/smll.20180487810.1002/smll.201804878 ↗